Notes to sections (a) – (j)
1 ElSohly, M.A. and Ross, S.A., “Quarterly Report, Potency Monitoring Project, Report #50” Washington, D.C.: NIDA, 1994. Table 1, pg. 3.
2 54 Fed. Reg. 53,768 (1989)
3 54 Fed. Reg. 53,771 (1989)
4 54 Fed. Reg. 53,773 (1989)
5 54 Fed. Reg. 53,774 (1989)
6 54 Fed. Reg. 53,776 (1989)
7 54 Fed. Reg. 53,781 (1989)
8 57 Fed. Reg. 10,499 (1992)
9 57 Fed. Reg. 10,499 (1992)
10 51 Fed. Reg. 17,476 (1986)
11 Nahas, G. Marihuana-Deceptive Weed. New York: Raven Press. 1973. pg. 98.
12 United States Pharmacopeial Convention, Inc. Volume I – Drug Information for the Health Care Professional. Taunton , MA: Rand McNally. 1995. pg. 1185.
13 57 Fed. Reg. 10,499 (1992)
14 57 Fed. Reg. 10,499 (1992)
15 57 Fed. Reg. 10,499 (1992)
16 54 Fed. Reg. 53,774 (1989)
17 Institute of Medicine (1982) pg. 12-15.
18 Institute of Medicine (1982) pg. 14.
19 Razdan, R. (1986) pg. 77.
20 ibid. pg. 82.
21 ibid. pg. 84 – 146.
22 ibid. pg. 146.
23 U.S. Department of Health and Human Services, (1987) Drug Abuse and Drug Abuse Research, the Second Triennial Report to Congress From the Secretary, Department of Health and Human Services. Washington, D.C.: Government Printing Office. 1987. (DHHS Publication No. (ADM8)7-1486) pg. 76.
24 ibid. pg. 78.
25 ibid. pg. 79.
26 ibid. pg. 79.
27 ibid. pg. 80.
28 ibid. pg. 82-83.
29 ibid. pg. 85-86.
30 ibid. pg. 88.
31 U.S. Department of Health and Human Services, (1991) Drug Abuse and Drug Abuse Research, the Third Triennial Report to Congress From the Secretary, Department of Health and Human Services. Washington, D.C.: Government Printing Office. 1991. (DHHS Publication No. (ADM9)1-1704)
32 Razdan, 1986 cited in HHS (1991) above.
33 Melvin, L.S., and Johnson, M.R. “Structure-activity relationships of tricyclic and nonclassical bicyclic cannabinoids.” In: Rapaka, R.S., and Makriyannis, A., eds. Structure-Activity Relationships of the Cannabinoids. National Institute on Drug Abuse Research Monograph 79, 1987. pp. 31-47. cited in HHS (1991) above.
34 HHS (1991) pg. 138-139.
35 Koob, G.B. and Bloom, F.E. (1988), “Cellular and molecular mechanisms of drug dependence.” Science, 242:715-723. cited in Oviedo, et al (1993) and in Pratt (1992).
36 Oviedo, et al. (1993) pg. 300.
37 Fan, F., Compton, D.R., et al. Development of Cross-Tolerance between D9-Tetrahydrocannabinol, CP 55,940 and WIN 55,212. Journal of Pharmacology and Experimental Therapeutics. 271:1383-1390, 1994.
38 ibid. pg. 1387.